
Clearmind Medicine Inc.
CMNDHealthcare|Biotechnology|CA
$5.58
-0.27 (-4.55%)
DCF Value
$8.03
Tangible Book / Share
$65.03
Cash / Share
$80.54
Ownership Breakdown
77.6%
Float
0.5M
Shares Outstanding
0.4M
Float Shares
Major Holders (5)
Combined: 40.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Richard Abbe | HC, IN | 9.99% | 346,667 | Aug 12, 2026 | 13D/G |
| Kimberly Page | Individual | 9.99% | 178,667 | Aug 12, 2026 | 13D/G |
| Iroquois Capital Management, LLC | Other | 9.99% | 178,667 | Aug 12, 2026 | 13D/G |
| Iroquois Capital Management L.L.C. | Other | 5.79% | 0 | Nov 14, 2024 | 13D/G |
| Gainor Lewis Berray | Individual | 4.90% | 25,300 | Oct 27, 2026 | 13D/G |
Insider Trades (10)
Last 4 quarters: 2,159,052 acquired · 252,615 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10 percent owner | Jun 16, 2026 | SELL | 22,139 | $3.31 | $73.2K | Form 4 |
| HRT FINANCIAL LP | 10 percent owner | Jun 15, 2026 | SELL | 3,183 | $3.32 | $10.6K | Form 4 |
| HRT FINANCIAL LP | 10 percent owner | Jun 12, 2026 | SELL | 2,102 | $3.36 | $7.1K | Form 4 |
| HRT FINANCIAL LP | 10 percent owner | Jun 10, 2026 | BUY | 2,159,052 | $0.15 | $330.3K | Form 4 |
| HRT FINANCIAL LP | 10 percent owner | Jun 11, 2026 | SELL | 225,191 | $0.12 | $27.7K | Form 4 |
| HRT FINANCIAL LP | 10 percent owner | Jun 10, 2026 | OTHER | 0 | — | — | Form 4 |
| Lamadrid David | director, 10 percent owner, officer: CEO and President | May 12, 2017 | AWARD | 857,143 | $0.35 | $300.0K | Form 4 |
| Lamadrid David | director, 10 percent owner, officer: CEO and President | May 1, 2017 | OTHER | 0 | — | — | Form 4 |
| Lamadrid David | director, 10 percent owner, officer: CEO and President | May 1, 2017 | DISPOSED | 0 | — | — | Form 4 |
| Lamadrid David | director, 10 percent owner, officer: CEO and President | May 1, 2017 | OTHER | 0 | — | — | Form 4 |